Publication | Closed Access

Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study

Neuro-oncologyOncologyMulticentric Retrospective StudyLong-term SurvivalImmune Checkpoint InhibitorNeurologyHigh-grade GliomasCancer TreatmentRecurrent GlioblastomaMedicineGliomaGlioblastoma